Genetic analysis of Staphylococcus aureus from intravenous drug user lesions

References

1. Becker K., Friedrich A. W., Lubritz G., Weilert M., Peters G., Von Eiff C. 2003; Prevalence of genes encoding pyrogenic toxin superantigens and exfoliative toxins among strains of Staphylococcus aureus isolated from blood and nasal specimens. J Clin Microbiol 41:1434–1439 [CrossRef]
   [Google Scholar]
2. Binswanger I. A., Kral A. H., Bluthenthal R. N., Rybold D. J., Edlin B. R. 2000; High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis 30:579–581 [CrossRef]
   [Google Scholar]
3. Bohach G. A., Dinges M. M., Mitchell D. T., Ohlendorf D. H., Schlievert P. M. 1997; Exotoxins. In The Staphylococci in Human Disease pp 83–111 Edited by Crossley K. B., Archer G. L. New York: Churchill Livingstone;
   [Google Scholar]
4. Enright M. C., Day N. P., Davies C. E., Peacock S. J., Spratt B. G. 2000; Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus . J Clin Microbiol 38:1008–1015
   [Google Scholar]
5. Enright M. C., Robinson D. A., Randle G., Feil E. J., Grundmann H., Spratt B. G. 2002; The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci U S A 99:7687–7692 [CrossRef]
   [Google Scholar]
6. Feil E. J., Cooper J. E., Grundmann H. & 9 other authors; 2003; How clonal is Staphylococcus aureus ?. J Bacteriol 185:3307–3316 [CrossRef]
   [Google Scholar]
7. Fleisch F., Zbinden R., Vanoli C., Ruef C. 2001; Epidemic spread of a single clone of methicillin-resistant Staphylococcus aureus among injection drug users in Zurich, Switzerland. Clin Infect Dis 32:581–586 [CrossRef]
   [Google Scholar]
8. Gillet Y., Issartel B., Vanhems P. & 8 other authors; 2002; Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359:753–759 [CrossRef]
   [Google Scholar]
9. Grundmann H., Hori S., Enright M. C., Webster C., Tami A., Feil E. J., Pitt T. 2002; Determining the genetic structure of the natural population of Staphylococcus aureus : a comparison of multilocus sequence typing with pulsed-field gel electrophoresis, randomly amplified polymorphic DNA analysis, and phage typing. J Clin Microbiol 40:4544–4546 [CrossRef]
   [Google Scholar]
10. Jarraud S., Lyon G. J., Figueiredo A. M. S., Gérard L., Vandenesch F., Etienne J., Muir T. W., Novick R. P. 2000; Exfoliatin-producing strains define a fourth agr specificity group in Staphylococcus aureus . J Bacteriol 182:6517–6522 [CrossRef]
    [Google Scholar]
11. Jarraud S., Mougel C., Thioulouse J., Lina G., Meugnier H., Forey F., Nesme X., Etienne J., Vandenesch F. 2002; Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect Immun 70:631–641 [CrossRef]
    [Google Scholar]
12. Ji G., Beavis R., Novick R. P. 1997; Bacterial interference caused by autoinducing peptide variants. Science 276:2027–2030 [CrossRef]
    [Google Scholar]
13. Lina G., Piemont Y., Godail-Gamot F., Bes M., Peter M. O., Gauduchon V., Vandenesch F., Etienne J. 1999; Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29:1128–1132 [CrossRef]
    [Google Scholar]
14. Lowy F. D., Miller M. 2002; New methods to investigate infectious disease transmission and pathogenesis – Staphylococcus aureus disease in drug users. Lancet Infect Dis 2:605–612 [CrossRef]
    [Google Scholar]
15. Peacock S. J., Moore C. E., Justice A., Kantzanou M., Story L., Mackie K., O'Neill G., Day N. P. 2002; Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus . Infect Immun 70:4987–4996 [CrossRef]
    [Google Scholar]
16. Spijkerman I. J., van Ameijden E. J., Mientjes G. H., Coutinho R. A., van den Hoek A. 1996; Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users. J Clin Epidemiol 49:1149–1154 [CrossRef]
    [Google Scholar]